Illumina, Inc. (ILMN) Tops Q2 EPS by 7c; Boosts Outlook

Illumina, Inc. (NASDAQ: ILMN) reported Q2 EPS of $0.57, $0.07 better than the analyst estimate of $0.50. Revenue for the quarter came in at $448 million versus the consensus estimate of $426.5 million.

“We are witnessing tremendous interest in our products, which led to record financial results in the second quarter,” stated Jay Flatley, CEO. “With the most extensive sequencing portfolio available, we remain extremely well-positioned to develop and address the large and untapped market opportunities ahead of us.”

Illumina, Inc. raised FY2014 EPS of $2.26-$2.28, versus the consensus of $2.17. Increased its full year 2014 guidance to 25% to 26% revenue growth

For earnings history and earnings-related data on Illumina, Inc. (ILMN) click here.

You May Also Be Interested In

• Novartis (NVS) Tops Q1 EPS by 13c, raises guidance
• US stock futures tread water with top tech earnings on tap
• JPMorgan is worried about further S&P 500 sell-off potential